Difficulty: Medium
Average Score: 85%
Testbank
A patient diagnosed with MS has been admitted to the medical unit for treatment of an MS exacerbation. Included in the admission orders is baclofen (Lioresal). What should the nurse identify as an expected outcome of this treatment?
Correct answer
B
Rationale
Decreased muscle spasms in the lower extremities is an expected outcome of baclofen treatment for a patient with MS. Baclofen is a muscle relaxant that specifically targets spasticity, which is a common symptom in multiple sclerosis, leading to reduced muscle spasms and improved mobility.
A: Reduction in the appearance of new lesions on the MRI does not directly relate to baclofen's action, as it primarily addresses muscle spasticity rather than inflammatory processes in MS.
C: Increased muscle strength in the upper extremities is not an expected outcome of baclofen, as the medication is designed to reduce spasticity rather than enhance muscle strength.
D: Decreased severity and duration of exacerbations is not applicable here, as baclofen does not modify the course of the disease or affect the frequency of exacerbations in MS.
A: Reduction in the appearance of new lesions on the MRI does not directly relate to baclofen's action, as it primarily addresses muscle spasticity rather than inflammatory processes in MS.
C: Increased muscle strength in the upper extremities is not an expected outcome of baclofen, as the medication is designed to reduce spasticity rather than enhance muscle strength.
D: Decreased severity and duration of exacerbations is not applicable here, as baclofen does not modify the course of the disease or affect the frequency of exacerbations in MS.